Resultados de búsqueda - C. Chouaïd

Limitar resultados
  1. 1
    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review

    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review por Kokuvi Atsou, C. Chouaïd, Gilles Hejblum

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date por S. Gendarme, Olivier Bylicki, C. Chouaïd, Florian Guisier

    Publicado 2022
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer

    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer por C. Chouaïd, Jean‐Baptiste Assié, J.B. Auliac

    Publicado 2025
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Delays for diagnosis and treatment of lung cancers: a systematic review

    Delays for diagnosis and treatment of lung cancers: a systematic review por F. Viñas, I. Ben Hassen, L. Jabot, I. Monnet, C. Chouaïd

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care

    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care por Olivier Bylicki, Morgane Didier, F. Rivière, J. Margery, F. Grassin, C. Chouaïd

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  6. 6
    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study

    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study por Laurent Laforest, Nicolás Roche, Gilles Devouassoux, Manon Belhassen, C. Chouaïd, M. Ginoux, Éric Van Ganse

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Lung cancer and interstitial lung disease: a literature review

    Lung cancer and interstitial lung disease: a literature review por Jean‐Marc Naccache, Q. Gibiot, I. Monnet, Martine Antoine, Marie Wislez, C. Chouaïd, Jacques Cadranel

    Publicado 2018
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  8. 8
    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-smal... por C. Chouaïd, L. Bensimon, E. Clay, A. Millier, L. Lévy-Bachelot, Min Huang, Pierre Lévy

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection

    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection por Joël Gozlan, J.‐M. Salord, C. Chouaïd, Claudine Duvivier, O Picard, Marie‐Caroline Meyohas, Jean‐Claude Petit

    Publicado 1993
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions

    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions por Alexis Ferré, C. Fuhrman, Mahmoud Zureik, C. Chouaïd, A. Vergnenègre, Gérard Huchon, Marie-Christine Delmas, Nicolás Roche

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials

    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials por Thierry Landre, G. Justeau, Jean‐Baptiste Assié, Kader Chouahnia, Claire Davoine, Chérifa Taleb, C. Chouaïd, Boris Duchemann

    Publicado 2021
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  12. 12
    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment

    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment por H. Picchi, Christine Mateus, C. Chouaïd, Benjamin Besse, Aurélien Marabelle, Jean‐Marie Michot, Stéphane Champiat, Anne-Laure Voisin, Olivier Lambotte

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Editorial
    Agregar a favoritos
    Guardado en:
  13. 13
    The association between asthma control, health care costs, and quality of life in France and Spain

    The association between asthma control, health care costs, and quality of life in France and Spain por Marianne Doz, C. Chouaïd, Laure Com-Ruelle, Eduardo Calvo, Max Brosa, J. Robert, L. Decuypère, C. Pribil, Alicia Huerta, B. Detournay

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis

    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis por Thierry Landre, Abdoulaye Karaboué, Zachary S. Buchwald, Pasquale F. Innominato, David C. Qian, Jean‐Baptiste Assié, C. Chouaïd, Françis Lévi, Boris Duchemann

    Publicado 2024
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  15. 15
    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain

    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain por Michel Maira, Christian Schnell, Pier‐Luigi Lollini, C. Chouaïd, Peter Schmid, Paolo Nanni, Dawn Lam, Emmanuelle di Tomaso, Cristian Massacesi, Jordi Rodón

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601) por C. Decroisette, I. Monnet, H. Bérard, Gilles Quéré, H. Le Caer, Suzanna Bota, Clarisse Audigier-Valette, L. Gérinière, Jean-Marc Vernejoux, C. Chouaïd

    Publicado 2011
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study por J. Le Treut, M. C. Sault, H. Léna, P.-J. Souquet, A. Vergnenègre, H. Le Caer, H. Bérard, S. Boffa, I. Monnet, Diane Damotte, C. Chouaïd

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC

    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC por Paul Lesueur, Alexandre Escande, Juliette Thariat, E. Vauléon, I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy por Romain-David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, G. Bonardel, C. Chouaïd, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion

    Publicado 2021
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis

    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis por Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, Anne-Françoise Gaudin, John R. Penrod, V. Grumberg, B. Jouaneton, R. Jolivel, Jean‐Baptiste Assié, C. Chouaïd

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: